BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nikonova AS, Deneka AY, Eckman L, Kopp MC, Hensley HH, Egleston BL, Golemis EA. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease. Front Oncol 2015;5:228. [PMID: 26528438 DOI: 10.3389/fonc.2015.00228] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Kiseleva AA, Korobeynikov VA, Nikonova AS, Zhang P, Makhov P, Deneka AY, Einarson MB, Serebriiskii IG, Liu H, Peterson JR, Golemis EA. Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs. Clin Cancer Res 2019;25:4179-93. [PMID: 30867219 DOI: 10.1158/1078-0432.CCR-18-3535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
2 Deneka AY, Haber L, Kopp MC, Gaponova AV, Nikonova AS, Golemis EA. Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model. PLoS One 2017;12:e0176747. [PMID: 28453558 DOI: 10.1371/journal.pone.0176747] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
3 Alfieri M, Iaconis D, Tammaro R, Perone L, Calì G, Nitsch L, Dougherty GW, Ragnini-Wilson A, Franco B. The centrosomal/basal body protein OFD1 is required for microtubule organization and cell cycle progression. Tissue Cell 2020;64:101369. [PMID: 32473706 DOI: 10.1016/j.tice.2020.101369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kiseleva AA, Nikonova AS, Golemis EA. Patterns of Ciliation and Ciliary Signaling in Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32761455 DOI: 10.1007/112_2020_36] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Korobeynikov V, Deneka AY, Golemis EA. Mechanisms for nonmitotic activation of Aurora-A at cilia. Biochem Soc Trans 2017;45:37-49. [PMID: 28202658 DOI: 10.1042/BST20160142] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
6 Olesen ETB, Fenton RA. Aquaporin 2 regulation: implications for water balance and polycystic kidney diseases. Nat Rev Nephrol 2021. [PMID: 34211154 DOI: 10.1038/s41581-021-00447-x] [Reference Citation Analysis]
7 Parker MI, Nikonova AS, Sun D, Golemis EA. Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease. Cell Signal 2020;67:109497. [PMID: 31830556 DOI: 10.1016/j.cellsig.2019.109497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Nikonova AS, Deneka AY, Kiseleva AA, Korobeynikov V, Gaponova A, Serebriiskii IG, Kopp MC, Hensley HH, Seeger-Nukpezah TN, Somlo S, Proia DA, Golemis EA. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD). FASEB J 2018;32:2735-46. [PMID: 29401581 DOI: 10.1096/fj.201700909R] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
9 Millet-Boureima C, He S, Le TBU, Gamberi C. Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease. Int J Mol Sci 2021;22:3918. [PMID: 33920158 DOI: 10.3390/ijms22083918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]